{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:49:52Z","timestamp":1791330592889,"version":"4.3.1"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/CRT\/21\/24268"],"award-info":[{"award-number":["FS\/CRT\/21\/24268"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/F\/21\/90009"],"award-info":[{"award-number":["CH\/F\/21\/90009"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/F\/21\/110040"],"award-info":[{"award-number":["RG\/F\/21\/110040"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005292","name":"Brigham and Women's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jcmg.2026.07.024","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:26:23Z","timestamp":1791231983000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodality Cardiovascular Imaging in the Evaluation of Cardiac Sarcoidosis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-4663","authenticated-orcid":false,"given":"Katharine E.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor C.","family":"Wicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0598-6502","authenticated-orcid":false,"given":"Sanjay","family":"Divakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikant","family":"Sabharwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Antoniades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Piechnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Y.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0046-7634","authenticated-orcid":false,"given":"Vanessa M.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2026.07.024_bib1","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS clinical statement on pulmonary sarcoidosis","volume":"76","author":"Thillai","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jcmg.2026.07.024_bib3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0735-1097(02)02715-8","article-title":"A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis","volume":"41","author":"Okura","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib5","first-page":"2663","article-title":"Cardiac manifestations of sarcoidosis: diagnosis and management","volume":"38","author":"Birnie","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2026.07.024_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021183","article-title":"Corticosteroid and immunosuppressant therapy for cardiac sarcoidosis: a systematic review","volume":"10","author":"Fazelpour","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jcmg.2026.07.024_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011253","article-title":"Myocardial involvement in patients with histologically diagnosed cardiac sarcoidosis: a systematic review and meta-analysis of gross pathological images from autopsy or cardiac transplantation cases","volume":"8","author":"Okasha","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jcmg.2026.07.024_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2026.07.024_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019415","article-title":"Manifestations and outcome of cardiac sarcoidosis and idiopathic giant cell myocarditis by 25-year nationwide cohorts","volume":"10","author":"Nordenswan","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jcmg.2026.07.024_bib10","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr\u00f6m","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2026.07.024_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.008975","article-title":"Diagnostic accuracy of advanced imaging in cardiac sarcoidosis","volume":"12","author":"Divakaran","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib12","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib13","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1161\/CIR.0000000000001240","article-title":"Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association","volume":"149","author":"Cheng","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2026.07.024_bib14","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis\u2014digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jcmg.2026.07.024_bib15","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2026.07.024_bib16","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/eurheartj\/ehae356","volume":"45","author":"Sharma","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2026.07.024_bib17","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jcmg.2026.07.024_bib18","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","author":"Hiraga","year":"2007","journal-title":"Jpn J Sarcoidosis Other Granulomatous Disord"},{"key":"10.1016\/j.jcmg.2026.07.024_bib19","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.jcmg.2026.07.024_bib20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jcmg.2025.02.010","article-title":"Global practices in cardiac imaging for cardiac sarcoidosis","volume":"18","author":"Kafil","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib21","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2026.07.024_bib22","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review","volume":"76","author":"Trivieri","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib23","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/eurheartj\/ehac323","article-title":"Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry","volume":"43","author":"Nabeta","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2026.07.024_bib24","doi-asserted-by":"crossref","first-page":"00516","DOI":"10.1183\/23120541.00516-2021","article-title":"Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis","volume":"8","author":"Ohira","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jcmg.2026.07.024_bib25","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/echo.13281","article-title":"Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction","volume":"33","author":"Murtagh","year":"2016","journal-title":"Echocardiography"},{"key":"10.1016\/j.jcmg.2026.07.024_bib27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/ehjci\/jez235","article-title":"Deterioration of biventricular strain is an early marker of cardiac involvement in confirmed sarcoidosis","volume":"21","author":"Kusunose","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12872-019-01323-0","article-title":"Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis","volume":"20","author":"Di Stefano","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jcmg.2026.07.024_bib29","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/echo.13846","article-title":"Global longitudinal strain and long-term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease","volume":"35","author":"Felekos","year":"2018","journal-title":"Echocardiography"},{"key":"10.1016\/j.jcmg.2026.07.024_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ejhf.205","article-title":"Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis","volume":"17","author":"Joyce","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcmg.2026.07.024_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014068","article-title":"Imaging methods: magnetic resonance imaging","volume":"16","author":"Thomas","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib32","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamacardio.2022.2981","article-title":"Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis","volume":"7","author":"Athwal","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib33","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2026.07.024_bib34","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.jcmg.2019.06.024","article-title":"Diagnostic specificity of basal inferoseptal triangular late gadolinium enhancement for identification of cardiac sarcoidosis","volume":"12","author":"Kuo","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jcmg.2022.10.018","article-title":"Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis","volume":"16","author":"Stevenson","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2020.11.044","article-title":"Risk and predictors of sudden death in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"328","author":"Franke","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib40","first-page":"634","article-title":"Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death","volume":"16","author":"Nadel","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jcmg.2022.11.012","article-title":"Prognostic value of RV abnormalities on CMR in patients with known or suspected cardiac sarcoidosis","volume":"16","author":"Wang","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib44","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jcmg.2019.12.011","article-title":"Right ventricular abnormalities on cardiovascular magnetic resonance imaging in patients with sarcoidosis","volume":"13","author":"Velangi","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib45","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jcmg.2025.02.012","article-title":"Extent and features of late gadolinium enhancement stratify arrhythmic risk in patients with biopsy-proven sarcoidosis","volume":"18","author":"Azzu","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib46","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2026.07.024_bib47","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2026.07.024_bib48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001728","article-title":"T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis","volume":"8","author":"Tonegawa-Kuji","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.jcmg.2026.07.024_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2026.07.024_bib51","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib52","article-title":"Multiparametric cardiovascular magnetic resonance in acute myocarditis: Comparison of 2009 and 2018 Lake louise criteria with endomyocardial biopsy confirmation","volume":"8","author":"Li","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004417","article-title":"Comprehensive cardiovascular magnetic resonance assessment in patients with sarcoidosis and preserved left ventricular ejection fraction","volume":"9","author":"Greulich","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","article-title":"Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping","volume":"189","author":"Crouser","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiol.2017162732","article-title":"T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis","volume":"285","author":"Puntmann","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.jcmg.2026.07.024_bib56","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s10554-023-02863-5","article-title":"Quantitative myocardial T2 mapping adds value to Japanese circulation society diagnostic criteria for active cardiac sarcoidosis","volume":"39","author":"Chamberlin","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib57","first-page":"131","article-title":"State-of-the-art review: stress T1 mapping\u2014technical considerations, pitfalls and emerging clinical applications. Magnetic resonance materials in physics","volume":"31","author":"Piechnik","year":"2018","journal-title":"Biol Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ehjci\/jead247","article-title":"Misclassification of females and males in cardiovascular magnetic resonance parametric mapping: the importance of sex-specific normal ranges for diagnosis of health vs. disease","volume":"25","author":"Thomas","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijcard.2021.01.026","article-title":"Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials \u2013 a T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study","volume":"330","author":"Zhang","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib60","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jcmg.2021.08.018","article-title":"Hybrid cardiac magnetic resonance\/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis","volume":"15","author":"Greulich","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41824-021-00119-w","article-title":"Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis","volume":"5","author":"Cheung","year":"2021","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib62","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jcmg.2020.02.001","article-title":"Substrate for the myocardial inflammation\u2013heart failure hypothesis identified using novel USPIO methodology","volume":"14","author":"Lagan","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib63","first-page":"101","article-title":"Visualization of immune cell infiltration in experimental viral myocarditis by 19F MRI in vivo. Magnetic resonance materials in physics","volume":"27","author":"Jacoby","year":"2014","journal-title":"Biol Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib64","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib65","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00259-024-06915-3","article-title":"EANM\/SNMMI guideline\/procedure standard for [(18)F]FDG hybrid PET use in infection and inflammation in adults v2.0","volume":"52","author":"Abikhzer","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib66","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s00259-013-2460-5","article-title":"Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis","volume":"40","author":"Manabe","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2018.10.083","article-title":"Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"284","author":"Protonotarios","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib69","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.125.017693","article-title":"How to use imaging: Cardiac sarcoidosis","volume":"18","author":"Divakaran","year":"2025","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133643","article-title":"Diagnoses and outcomes of patients referred for FDG PET\/CT for suspected cardiac sarcoidosis","volume":"439","author":"Hankinson","year":"2025","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib71","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/ehf2.15154","article-title":"FDG PET\/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy","volume":"12","author":"Divakaran","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jcmg.2026.07.024_bib72","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jcmg.2025.09.005","article-title":"Patterns of nonspecific myocardial FDG uptake in patients without sarcoidosis with normal CMR","volume":"19","author":"Hankinson","year":"2026","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2025.102581","article-title":"Prevalence of lateral wall myocardial fluorodeoxyglucose uptake in patients with left bundle branch block or ventricular pacing referred for sarcoidosis fluorodeoxyglucose positron emission tomography\/computed tomography imaging","volume":"57","author":"Mannan","year":"2026","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euag050","article-title":"Ventricular tachycardia ablation associated abnormalities on FDG PET\/CT in patients with suspected cardiac sarcoidosis","volume":"28","author":"Kazzi","year":"2026","journal-title":"Europace"},{"key":"10.1016\/j.jcmg.2026.07.024_bib75","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s12350-019-01755-3","article-title":"Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis\u20142018 update: japanese Society of Nuclear Cardiology recommendations","volume":"26","author":"Kumita","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib76","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","volume":"25","author":"Slart","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib77","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12350-019-01746-4","article-title":"Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: the effect of a structured patient preparation protocol","volume":"28","author":"Christopoulos","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib78","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"Manabe","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib79","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.016774","article-title":"Relationship of ketosis with myocardial glucose uptake among patients undergoing FDG PET\/CT for evaluation of cardiac sarcoidosis","volume":"17","author":"Vidula","year":"2024","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101842","article-title":"Role of serial (18)F-fludeoxyglucose positron emission tomography in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis","volume":"35","author":"Okafor","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib81","article-title":"Building consensus on advanced imaging in cardiac sarcoidosis","author":"Divakaran","year":"2025","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib82","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102088","article-title":"Quantification of metabolic activity in the evaluation of cardiac sarcoidosis","volume":"43","author":"Wiefels","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib84","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/diagnostics12020528","article-title":"Clinical applications of somatostatin receptor (Agonist) PET tracers beyond neuroendocrine tumors","volume":"12","author":"Helgebostad","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jcmg.2026.07.024_bib85","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2967\/jnumed.107.044578","article-title":"Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT","volume":"49","author":"Zhao","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of (18)F-FLT and (18)F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jcmg.2026.07.024_bib87","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s12350-019-01976-6","article-title":"(18)F-FMISO PET\/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis","volume":"28","author":"Furuya","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib88","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/qjmed\/hcae067","article-title":"Fibroblast activation in sarcoidosis as assessed by 68Ga-FAPI (fibroblast activation protein inhibitor)-46 PET\/CT","volume":"117","author":"O\u2019Brien","year":"2024","journal-title":"Qjm"},{"key":"10.1016\/j.jcmg.2026.07.024_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101835","article-title":"Potential application of (68)Ga-FAPI PET\/CT for diagnosing cardiac sarcoidosis","volume":"36","author":"Solanki","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib90","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.117.196485","article-title":"Clinical molecular imaging of chemokine receptor CXCR4 expression in atherosclerotic plaque using (68)Ga-Pentixafor PET: correlation with cardiovascular risk factors and calcified plaque burden","volume":"59","author":"Weiberg","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib91","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178711","article-title":"Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases","volume":"134","author":"Sati","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcmg.2026.07.024_bib92","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41586-024-08441-6","article-title":"CD45-PET is a robust, non-invasive tool for imaging inflammation","volume":"639","author":"Salehi","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jcmg.2026.07.024_bib93","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01290-2016","article-title":"Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013","volume":"49","author":"Ungprasert","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcmg.2026.07.024_bib94","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1007\/s00330-017-4824-x","article-title":"Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: a feasibility study","volume":"27","author":"Aikawa","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib95","doi-asserted-by":"crossref","DOI":"10.1097\/nm9.0000000000000057","article-title":"FDG PET-CT in the setting of inconclusive cardiac MRI: real-world observations in cardiac sarcoidosis","volume":"2","author":"Paci","year":"2025","journal-title":"Clin Nucl Med Open"},{"key":"10.1016\/j.jcmg.2026.07.024_bib96","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/radiol.213170","article-title":"Diagnostic accuracy of cardiac MRI versus FDG PET for cardiac sarcoidosis: a systematic review and meta-analysis","volume":"304","author":"Aitken","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.jcmg.2026.07.024_bib98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41824-018-0030-6","article-title":"PET\/MRI: a frontier in era of complementary hybrid imaging","volume":"2","author":"Musafargani","year":"2018","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib99","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2023.11.010","article-title":"Hybrid magnetic resonance positron emission tomography is associated with cardiac-related outcomes in cardiac sarcoidosis","volume":"17","author":"Trivieri","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib100","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jcmg.2019.12.013","article-title":"Effect of corticosteroid dose and duration on 18-Fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"13","author":"Okada","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcmg.2023.05.017","article-title":"Prospective analysis of immunosuppressive therapy in cardiac sarcoidosis with fluorodeoxyglucose myocardial accumulation","volume":"17","author":"Morimoto","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib102","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib103","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jcmg.2024.05.013","article-title":"Risk stratification in cardiac sarcoidosis with cardiac positron emission tomography: a systematic review and meta-analysis","volume":"17","author":"Kafil","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib104","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/jim-2016-000144","article-title":"Resolution of abnormal cardiac mri T2 signal following immune suppression for cardiac sarcoidosis","volume":"64","author":"Crouser","year":"2016","journal-title":"J Invest Med"},{"key":"10.1016\/j.jcmg.2026.07.024_bib105","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1093\/eurheartj\/ehaf338","article-title":"Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs societal recommendations for implantable cardioverter-defibrillator placement","volume":"46","author":"Mathijssen","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2026.07.024_bib106","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/ehjci\/jeaf074","article-title":"The role of FDG-PET\/CT in assessing cardiac sarcoidosis with no high-risk cardiac features and normal CMR","volume":"26","author":"Shuduyeva","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2026.07.024_bib110","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.123.011869","article-title":"Interleukin-1 blockade in cardiac sarcoidosis: a pilot study","volume":"16","author":"Kron","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jcmg.2026.07.024_bib111","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)","volume":"220","author":"Birnie","year":"2020","journal-title":"Am Heart J"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X26004493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X26004493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:51:35Z","timestamp":1791327095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X26004493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":107,"alternative-id":["S1936878X26004493"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2026.07.024","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodality Cardiovascular Imaging in the Evaluation of Cardiac Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2026.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}